King's College London

Research portal

Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing

Research output: Contribution to journalArticle

Standard

Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. / Von Wagner, Christian; Cadar, Dorina; Hackett, Ruth A; Demakakos, Panayotes; Beeken, Rebecca J; Cooper Bailey, Stacy; Wolf, Michael; Steptoe, Andrew; Renzi, Cristina; Stoffel, Sandro T.

In: Journal of Medical Screening, Vol. 27, No. 1, 01.03.2020, p. 25-30.

Research output: Contribution to journalArticle

Harvard

Von Wagner, C, Cadar, D, Hackett, RA, Demakakos, P, Beeken, RJ, Cooper Bailey, S, Wolf, M, Steptoe, A, Renzi, C & Stoffel, ST 2020, 'Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing', Journal of Medical Screening, vol. 27, no. 1, pp. 25-30. https://doi.org/10.1177/0969141319874834

APA

Von Wagner, C., Cadar, D., Hackett, R. A., Demakakos, P., Beeken, R. J., Cooper Bailey, S., Wolf, M., Steptoe, A., Renzi, C., & Stoffel, S. T. (2020). Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. Journal of Medical Screening, 27(1), 25-30. https://doi.org/10.1177/0969141319874834

Vancouver

Von Wagner C, Cadar D, Hackett RA, Demakakos P, Beeken RJ, Cooper Bailey S et al. Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. Journal of Medical Screening. 2020 Mar 1;27(1):25-30. https://doi.org/10.1177/0969141319874834

Author

Von Wagner, Christian ; Cadar, Dorina ; Hackett, Ruth A ; Demakakos, Panayotes ; Beeken, Rebecca J ; Cooper Bailey, Stacy ; Wolf, Michael ; Steptoe, Andrew ; Renzi, Cristina ; Stoffel, Sandro T. / Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. In: Journal of Medical Screening. 2020 ; Vol. 27, No. 1. pp. 25-30.

Bibtex Download

@article{2611a2f994f246ddbee69f8684a8b460,
title = "Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing",
abstract = "Objectives: Type 2 diabetes has been identified as a risk factor for colorectal cancer, but little is known about whether it influences participation in colorectal cancer screening programmes. This study tested the extent to which Type 2 diabetes is negatively associated with colorectal cancer screening uptake. Methods: We analysed individual data of screening eligible men and women aged 60–75 without cancer diagnosis from wave 6 of the English Longitudinal Study of Ageing (collected 2012–2013), to investigate whether Type 2 Diabetes influences colorectal cancer screening behaviour independently of demographic characteristics, body mass index, socio-economic status and other chronic diseases. Results: Individuals who reported to have Type 2 diabetes or had glycated haemoglobin (HbA1c) levels of 48 mmol/mol or higher were less likely to have ever completed a screening test (faecal occult blood test; 62.8% vs. 75.8%, p < 0.01) or to be up-to-date with their biennial screening invitation (60.2% vs. 72.0%, p < 0.05). The negative associations of Type 2 diabetes on colorectal cancer screening were found both in unadjusted and adjusted regression models. Conclusions: Future qualitative and quantitative research should identify reasons for this discrepancy, to inform interventions to increase screening uptake in this high-risk population.",
keywords = "Bowel cancer, bowel cancer screening, colorectal cancer screening, comorbidities, diabetes, screening participation",
author = "{Von Wagner}, Christian and Dorina Cadar and Hackett, {Ruth A} and Panayotes Demakakos and Beeken, {Rebecca J} and {Cooper Bailey}, Stacy and Michael Wolf and Andrew Steptoe and Cristina Renzi and Stoffel, {Sandro T}",
year = "2020",
month = mar,
day = "1",
doi = "10.1177/0969141319874834",
language = "English",
volume = "27",
pages = "25--30",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications Ltd",
number = "1",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing

AU - Von Wagner, Christian

AU - Cadar, Dorina

AU - Hackett, Ruth A

AU - Demakakos, Panayotes

AU - Beeken, Rebecca J

AU - Cooper Bailey, Stacy

AU - Wolf, Michael

AU - Steptoe, Andrew

AU - Renzi, Cristina

AU - Stoffel, Sandro T

PY - 2020/3/1

Y1 - 2020/3/1

N2 - Objectives: Type 2 diabetes has been identified as a risk factor for colorectal cancer, but little is known about whether it influences participation in colorectal cancer screening programmes. This study tested the extent to which Type 2 diabetes is negatively associated with colorectal cancer screening uptake. Methods: We analysed individual data of screening eligible men and women aged 60–75 without cancer diagnosis from wave 6 of the English Longitudinal Study of Ageing (collected 2012–2013), to investigate whether Type 2 Diabetes influences colorectal cancer screening behaviour independently of demographic characteristics, body mass index, socio-economic status and other chronic diseases. Results: Individuals who reported to have Type 2 diabetes or had glycated haemoglobin (HbA1c) levels of 48 mmol/mol or higher were less likely to have ever completed a screening test (faecal occult blood test; 62.8% vs. 75.8%, p < 0.01) or to be up-to-date with their biennial screening invitation (60.2% vs. 72.0%, p < 0.05). The negative associations of Type 2 diabetes on colorectal cancer screening were found both in unadjusted and adjusted regression models. Conclusions: Future qualitative and quantitative research should identify reasons for this discrepancy, to inform interventions to increase screening uptake in this high-risk population.

AB - Objectives: Type 2 diabetes has been identified as a risk factor for colorectal cancer, but little is known about whether it influences participation in colorectal cancer screening programmes. This study tested the extent to which Type 2 diabetes is negatively associated with colorectal cancer screening uptake. Methods: We analysed individual data of screening eligible men and women aged 60–75 without cancer diagnosis from wave 6 of the English Longitudinal Study of Ageing (collected 2012–2013), to investigate whether Type 2 Diabetes influences colorectal cancer screening behaviour independently of demographic characteristics, body mass index, socio-economic status and other chronic diseases. Results: Individuals who reported to have Type 2 diabetes or had glycated haemoglobin (HbA1c) levels of 48 mmol/mol or higher were less likely to have ever completed a screening test (faecal occult blood test; 62.8% vs. 75.8%, p < 0.01) or to be up-to-date with their biennial screening invitation (60.2% vs. 72.0%, p < 0.05). The negative associations of Type 2 diabetes on colorectal cancer screening were found both in unadjusted and adjusted regression models. Conclusions: Future qualitative and quantitative research should identify reasons for this discrepancy, to inform interventions to increase screening uptake in this high-risk population.

KW - Bowel cancer

KW - bowel cancer screening

KW - colorectal cancer screening

KW - comorbidities

KW - diabetes

KW - screening participation

UR - http://www.scopus.com/inward/record.url?scp=85073948674&partnerID=8YFLogxK

U2 - 10.1177/0969141319874834

DO - 10.1177/0969141319874834

M3 - Article

VL - 27

SP - 25

EP - 30

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

IS - 1

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454